Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation

Stem Cell Research

Volumn 13, Issue 3, 2014, Pages 571-581

  Lin, Zhiqiang ^a   Pu, William T ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; PROTEIN HIPPO; UNCLASSIFIED DRUG; HIPPO PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

APOPTOSIS; CELL PROLIFERATION; HEART DEVELOPMENT; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART REGENERATION; HEART REJUVENATION; HEART VENTRICLE HYPERTROPHY; NONHUMAN; ORGAN GROWTH; REGENERATION; REGULATORY MECHANISM; REJUVENATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; ENZYMOLOGY; GENETICS; HEART; HEART DISEASES; HUMAN; METABOLISM; PATHOPHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; HEART; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; REGENERATION; REJUVENATION; SIGNAL TRANSDUCTION;

EID: 84911446779     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.04.010     Document Type: Review

References (73)

1. Adler J.J., Johnson D.E., Heller B.L., Bringman L.R., Ranahan W.P., Conwell M.D., Sun Y., Hudmon A., Wells C.D. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of angiomotin by the LATS1/2 protein kinases. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:17368-17373.
2. Baliga R.R., Pimental D.R., Zhao Y.Y., Simmons W.W., Marchionni M.A., Sawyer D.B., Kelly R.A. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am. J. Physiol. 1999, 277:H2026-H2037.
3. Barry E.R., Morikawa T., Butler B.L., Shrestha K., de la Rosa R., Yan K.S., Fuchs C.S., Magness S.T., Smits R., Ogino S., Kuo C.J., Camargo F.D. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 2013, 493:106-110.
4. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabe-Heider F., Walsh S., Zupicich J., Alkass K., Buchholz B.A., Druid H., Jovinge S., Frisen J. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
5. Bersell K., Arab S., Haring B., Kuhn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009, 138:257-270.
6. Brunet A., Kanai F., Stehn J., Xu J., Sarbassova D., Frangioni J.V., Dalal S.N., Decaprio J.A., Greenberg M.E., Yaffe M.B. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 2002, 156:817-828.
7. Cai J., Zhang N., Zheng Y., de Wilde R.F., Maitra A., Pan D. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 2010, 24:2383-2388.
8. Camargo F.D., Gokhale S., Johnnidis J.B., Fu D., Bell G.W., Jaenisch R., Brummelkamp T.R. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 2007, 17:2054-2060.
9. Cao X., Pfaff S.L., Gage F.H. YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev. 2008, 22:3320-3334.
10. Chan S.W., Lim C.J., Guo F., Tan I., Leung T., Hong W. Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation. J. Biol. Chem. 2013, 288:37296-37307.
11. Chen Z., Friedrich G.A., Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev. 1994, 8:2293-2301.
12. Creasy C.L., Chernoff J. Cloning and characterization of a human protein kinase with homology to Ste20. J. Biol. Chem. 1995, 270:21695-21700.
13. Dai X., She P., Chi F., Feng Y., Liu H., Jin D., Zhao Y., Guo X., Jiang D., Guan K.L., Zhong T.P., Zhao B. Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration and angiogenesis. J. Biol. Chem. 2013, 288:34041-34051.
14. Dargie H. Heart failure post-myocardial infarction: a review of the issues. Heart 2005, 91(Suppl. 2):ii3-ii6. (discussion ii31, ii43-8).
15. Del Re D.P., Yang Y., Nakano N., Cho J., Zhai P., Yamamoto T., Zhang N., Yabuta N., Nojima H., Pan D., Sadoshima J. Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J. Biol. Chem. 2013, 288:3977-3988.
16. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., Gayyed M.F., Anders R.A., Maitra A., Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
17. Duerr R.L., Huang S., Miraliakbar H.R., Clark R., Chien K.R., Ross J.J. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 1995, 95:619-627.
18. Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., Zanconato F., Le Digabel J., Forcato M., Bicciato S., Elvassore N., Piccolo S. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474:179-183.
19. Eckardt N.A. Transcription factors dial 14-3-3 for nuclear shuttle. Plant Cell 2001, 13:2385-2389.
20. Emoto K., Parrish J.Z., Jan L.Y., Jan Y.N. The tumour suppressor Hippo acts with the NDR kinases in dendritic tiling and maintenance. Nature 2006, 443:210-213.
21. Engel F.B., Schebesta M., Duong M.T., Lu G., Ren S., Madwed J.B., Jiang H., Wang Y., Keating M.T. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 2005, 19:1175-1187.
22. Fernandez B.G., Gaspar P., Bras-Pereira C., Jezowska B., Rebelo S.R., Janody F. Actin-capping protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development 2011, 138:2337-2346.
23. Hamaratoglu F., Willecke M., Kango-Singh M., Nolo R., Hyun E., Tao C., Jafar-Nejad H., Halder G. The tumour-suppressor genes NF2/merlin and expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat. Cell Biol. 2006, 8:27-36.
24. Heallen T., Zhang M., Wang J., Bonilla-Claudio M., Klysik E., Johnson R.L., Martin J.F. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332:458-461.
25. Heallen T., Morikawa Y., Leach J., Tao G., Willerson J.T., Johnson R.L., Martin J.F. Hippo signaling impedes adult heart regeneration. Development 2013, 140:4683-4690.
26. House S.L., House B.E., Glascock B., Kimball T., Nusayr E., Schultz J.E., Doetschman T. Fibroblast growth factor 2 mediates isoproterenol-induced cardiac hypertrophy through activation of the extracellular regulated Kinase. Mol. Cell. Pharmacol. 2010, 2:143-154.
27. Hsieh P.C., Segers V.F., Davis M.E., MacGillivray C., Gannon J., Molkentin J.D., Robbins J., Lee R.T. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 2007, 13:970-974.
28. Huang J., Wu S., Barrera J., Matthews K., Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005, 122:421-434.
29. Imajo M., Miyatake K., Iimura A., Miyamoto A., Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling. EMBO J. 2012, 31:1109-1122.
30. Jukam D., Xie B., Rister J., Terrell D., Charlton-Perkins M., Pistillo D., Gebelein B., Desplan C., Cook T. Opposite feedbacks in the Hippo pathway for growth control and neural fate. Science 2013, 342:1238016.
31. Kajstura J., Hosoda T., Bearzi C., Rota M., Maestroni S., Urbanek K., Leri A., Anversa P. The human heart: a self-renewing organ. Clin. Transl. Sci. 2008, 1:80-86.
32. Konsavage W.M.J., Kyler S.L., Rennoll S.A., Jin G., Yochum G.S. Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J. Biol. Chem. 2012, 287:11730-11739.
33. Kuhn B., del Monte F., Hajjar R.J., Chang Y.S., Lebeche D., Arab S., Keating M.T. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 2007, 13:962-969.
34. Lai Z.C., Wei X., Shimizu T., Ramos E., Rohrbaugh M., Nikolaidis N., Ho L.L., Li Y. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 2005, 120:675-685.
35. Lian I., Kim J., Okazawa H., Zhao J., Zhao B., Yu J., Chinnaiyan A., Israel M.A., Goldstein L.S., Abujarour R., Ding S., Guan K.L. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 2010, 24:1106-1118.
36. Maejima Y., Kyoi S., Zhai P., Liu T., Li H., Ivessa A., Sciarretta S., Del Re D.P., Zablocki D.K., Hsu C.P., Lim D.S., Isobe M., Sadoshima J. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat. Med. 2013, 19:1478-1488.
37. Matallanas D., Romano D., Hamilton G., Kolch W., O'Neill E. A Hippo in the ointment: MST signalling beyond the fly. Cell Cycle 2008, 7:879-884.
38. Matsui Y., Nakano N., Shao D., Gao S., Luo W., Hong C., Zhai P., Holle E., Yu X., Yabuta N., Tao W., Wagner T., Nojima H., Sadoshima J. Lats2 is a negative regulator of myocyte size in the heart. Circ. Res. 2008, 103:1309-1318.
39. McMullen J.R., Shioi T., Huang W.Y., Zhang L., Tarnavski O., Bisping E., Schinke M., Kong S., Sherwood M.C., Brown J., Riggi L., Kang P.M., Izumo S. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J. Biol. Chem. 2004, 279:4782-4793.
40. Mehra M.R., Uber P.A., Francis G.S. Heart failure therapy at a crossroad: are there limits to the neurohormonal model?. J. Am. Coll. Cardiol. 2003, 41:1606-1610.
41. Odashima M., Usui S., Takagi H., Hong C., Liu J., Yokota M., Sadoshima J. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ. Res. 2007, 100:1344-1352.
42. Oka T., Xu J., Kaiser R.A., Melendez J., Hambleton M., Sargent M.A., Lorts A., Brunskill E.W., GWn Dorn, Conway S.J., Aronow B.J., Robbins J., Molkentin J.D. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ. Res. 2007, 101:313-321.
43. Pan D. Hippo signaling in organ size control. Genes Dev. 2007, 21:886-897.
44. Pobbati A.V., Hong W. Emerging roles of TEAD transcription factors and its coactivators in cancers. Cancer Biol. Ther. 2013, 14:390-398.
45. Porrello E.R., Mahmoud A.I., Simpson E., Hill J.A., Richardson J.A., Olson E.N., Sadek H.A. Transient regenerative potential of the neonatal mouse heart. Science 2011, 331:1078-1080.
46. Schlegelmilch K., Mohseni M., Kirak O., Pruszak J., Rodriguez J.R., Zhou D., Kreger B.T., Vasioukhin V., Avruch J., Brummelkamp T.R., Camargo F.D. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 2011, 144:782-795.
47. Senyo S.E., Steinhauser M.L., Pizzimenti C.L., Yang V.K., Cai L., Wang M., Wu T.D., Guerquin-Kern J.L., Lechene C.P., Lee R.T. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013, 493:433-436.
48. Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 1994, 9:2145-2152.
49. Tao W., Zhang S., Turenchalk G.S., Stewart R.A., St John M.A., Chen W., Xu T. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat. Genet. 1999, 21:177-181.
50. Tapon N., Harvey K.F., Bell D.W., Wahrer D.C., Schiripo T.A., Haber D., Hariharan I.K. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 2002, 110:467-478.
51. Tomlinson V., Gudmundsdottir K., Luong P., Leung K.Y., Knebel A., Basu S. JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis. 2010, 1:e29.
52. Tsika R.W., Ma L., Kehat I., Schramm C., Simmer G., Morgan B., Fine D.M., Hanft L.M., McDonald K.S., Molkentin J.D., Krenz M., Yang S., Ji J. TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction. J. Biol. Chem. 2010, 285:13721-13735.
53. von Gise A., Lin Z., Schlegelmilch K., Honor L.B., Pan G.M., Buck J.N., Ma Q., Ishiwata T., Zhou B., Camargo F.D., Pu W.T. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2394-2399.
54. Wang K., Degerny C., Xu M., Yang X.J. YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem. Cell Biol. 2009, 87:77-91.
55. Wang J., Park J.S., Wei Y., Rajurkar M., Cotton J.L., Fan Q., Lewis B.C., Ji H., Mao J. TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPalpha function. Mol. Cell 2013, 51:211-225.
56. Wu S., Huang J., Dong J., Pan D. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 2003, 114:445-456.
57. Wu S., Liu Y., Zheng Y., Dong J., Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev. Cell 2008, 14:388-398.
58. Xiao J.H., Davidson I., Matthes H., Garnier J.M., Chambon P. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 1991, 65:551-568.
59. Xin M., Kim Y., Sutherland L.B., Qi X., McAnally J., Schwartz R.J., Richardson J.A., Bassel-Duby R., Olson E.N. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal. 2011, 4:ra70.
60. Xin M., Kim Y., Sutherland L.B., Murakami M., Qi X., McAnally J., Porrello E.R., Mahmoud A.I., Tan W., Shelton J.M., Richardson J.A., Sadek H.A., Bassel-Duby R., Olson E.N. Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:13839-13844.
61. Xu T., Wang W., Zhang S., Stewart R.A., Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 1995, 121:1053-1063.
62. Yamamoto S., Yang G., Zablocki D., Liu J., Hong C., Kim S.J., Soler S., Odashima M., Thaisz J., Yehia G., Molina C.A., Yatani A., Vatner D.E., Vatner S.F., Sadoshima J. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J. Clin. Invest. 2003, 111:1463-1474.
63. Yin F., Yu J., Zheng Y., Chen Q., Zhang N., Pan D. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 2013, 154:1342-1355.
64. Yoshida T. MCAT elements and the TEF-1 family of transcription factors in muscle development and disease. Arterioscler. Thromb. Vasc. Biol. 2008, 28:8-17.
65. Yu F.X., Guan K.L. The Hippo pathway: regulators and regulations. Genes Dev. 2013, 27:355-371.
66. Yu F.X., Zhao B., Panupinthu N., Jewell J.L., Lian I., Wang L.H., Zhao J., Yuan H., Tumaneng K., Li H., Fu X.D., Mills G.B., Guan K.L. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012, 150:780-791.
67. Zaidi S.K., Sullivan A.J., Medina R., Ito Y., van Wijnen A.J., Stein J.L., Lian J.B., Stein G.S. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 2004, 23:790-799.
68. Zhang L., Ren F., Zhang Q., Chen Y., Wang B., Jiang J. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev. Cell 2008, 14:377-387.
69. Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., Xie J., Ikenoue T., Yu J., Li L., Zheng P., Ye K., Chinnaiyan A., Halder G., Lai Z.C., Guan K.L. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007, 21:2747-2761.
70. Zhao B., Ye X., Yu J., Li L., Li W., Li S., Yu J., Lin J.D., Wang C.Y., Chinnaiyan A.M., Lai Z.C., Guan K.L. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008, 22:1962-1971.
71. Zhao B., Li L., Lei Q., Guan K.L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010, 24:862-874.
72. Zhao B., Li L., Lu Q., Wang L.H., Liu C.Y., Lei Q., Guan K.L. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011, 25:51-63.
73. Zhou B., Lin Z., Pu W.T. Mammalian myocardial regeneration. Muscle: Fundamental Biology and Mechanisms of Disease 2012, 555-569. Elsevier. J.A. Hill, E. Olson (Eds.).